APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ondansetron Hydrochloride Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ondansetron Hydrochloride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchOndansetron Hydrochloride Tablets Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Ondansetron Hydrochloride Tablets Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Ondansetron Hydrochloride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ondansetron Hydrochloride Tablets Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ondansetron Hydrochloride Tablets Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Ondansetron Hydrochloride Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ondansetron Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ondansetron Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ondansetron Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ondansetron Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ondansetron Hydrochloride Tablets include GSK, Aden Healthcare, Aurobindo Pharma, Henry Schein, Morningside Pharmaceuticals, Mylan, Novartis, Takeda and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ondansetron Hydrochloride Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ondansetron Hydrochloride Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ondansetron Hydrochloride Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ondansetron Hydrochloride Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Ondansetron Hydrochloride Tablets Segment by Company

GSK

Aden Healthcare

Aurobindo Pharma

Henry Schein

Morningside Pharmaceuticals

Mylan

Novartis

Takeda

Teva

PKU Healthcare

Ningbo Tianheng Pharmaceutical

Qilu Pharmaceutical

Shanghai Pharmaceuticals

SJZ No.4 Pharmaceutical

Ondansetron Hydrochloride Tablets Segment by Type

Ordinary Tablets

Oraliy Disintegrating Tablets

Ondansetron Hydrochloride Tablets Segment by Application

Pharmacy

Hospital and Clinic

Other

Ondansetron Hydrochloride Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ondansetron Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ondansetron Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ondansetron Hydrochloride Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ondansetron Hydrochloride Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ondansetron Hydrochloride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ondansetron Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ondansetron Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ondansetron Hydrochloride Tablets Industry Trends Table 2. Ondansetron Hydrochloride Tablets Industry Drivers Table 3. Ondansetron Hydrochloride Tablets Industry Opportunities and Challenges Table 4. Ondansetron Hydrochloride Tablets Industry Restraints Table 5. Global Ondansetron Hydrochloride Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ondansetron Hydrochloride Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ondansetron Hydrochloride Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Ondansetron Hydrochloride Tablets Sales Market Share by Manufacturers Table 9. Global Ondansetron Hydrochloride Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Ondansetron Hydrochloride Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ondansetron Hydrochloride Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ondansetron Hydrochloride Tablets Manufacturers, Product Type & Application Table 13. Global Ondansetron Hydrochloride Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ondansetron Hydrochloride Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Ordinary Tablets Table 17. Major Manufacturers of Oraliy Disintegrating Tablets Table 18. Global Ondansetron Hydrochloride Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Ondansetron Hydrochloride Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Ondansetron Hydrochloride Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Ondansetron Hydrochloride Tablets Sales Market Share by Type (2021-2026) Table 22. Global Ondansetron Hydrochloride Tablets Sales Market Share by Type (2027-2032) Table 23. Global Ondansetron Hydrochloride Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Ondansetron Hydrochloride Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Ondansetron Hydrochloride Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Ondansetron Hydrochloride Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Ondansetron Hydrochloride Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pharmacy Table 29. Major Manufacturers of Hospital and Clinic Table 30. Major Manufacturers of Other Table 31. Global Ondansetron Hydrochloride Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Ondansetron Hydrochloride Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Ondansetron Hydrochloride Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Ondansetron Hydrochloride Tablets Sales Market Share by Application (2021-2026) Table 35. Global Ondansetron Hydrochloride Tablets Sales Market Share by Application (2027-2032) Table 36. Global Ondansetron Hydrochloride Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Ondansetron Hydrochloride Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Ondansetron Hydrochloride Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Ondansetron Hydrochloride Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Ondansetron Hydrochloride Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Ondansetron Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Ondansetron Hydrochloride Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Ondansetron Hydrochloride Tablets Sales Market Share by Region (2021-2026) Table 44. Global Ondansetron Hydrochloride Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Ondansetron Hydrochloride Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Ondansetron Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Ondansetron Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Ondansetron Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Ondansetron Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Ondansetron Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Ondansetron Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Ondansetron Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Ondansetron Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Ondansetron Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Ondansetron Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Ondansetron Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Ondansetron Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Ondansetron Hydrochloride Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Ondansetron Hydrochloride Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Ondansetron Hydrochloride Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Ondansetron Hydrochloride Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Ondansetron Hydrochloride Tablets Revenue Market Share by Region (2027-2032) Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. GSK Ondansetron Hydrochloride Tablets Product Portfolio Table 67. GSK Recent Development Table 68. Aden Healthcare Company Information Table 69. Aden Healthcare Business Overview Table 70. Aden Healthcare Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Aden Healthcare Ondansetron Hydrochloride Tablets Product Portfolio Table 72. Aden Healthcare Recent Development Table 73. Aurobindo Pharma Company Information Table 74. Aurobindo Pharma Business Overview Table 75. Aurobindo Pharma Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Aurobindo Pharma Ondansetron Hydrochloride Tablets Product Portfolio Table 77. Aurobindo Pharma Recent Development Table 78. Henry Schein Company Information Table 79. Henry Schein Business Overview Table 80. Henry Schein Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Henry Schein Ondansetron Hydrochloride Tablets Product Portfolio Table 82. Henry Schein Recent Development Table 83. Morningside Pharmaceuticals Company Information Table 84. Morningside Pharmaceuticals Business Overview Table 85. Morningside Pharmaceuticals Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Morningside Pharmaceuticals Ondansetron Hydrochloride Tablets Product Portfolio Table 87. Morningside Pharmaceuticals Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Mylan Ondansetron Hydrochloride Tablets Product Portfolio Table 92. Mylan Recent Development Table 93. Novartis Company Information Table 94. Novartis Business Overview Table 95. Novartis Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Novartis Ondansetron Hydrochloride Tablets Product Portfolio Table 97. Novartis Recent Development Table 98. Takeda Company Information Table 99. Takeda Business Overview Table 100. Takeda Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Takeda Ondansetron Hydrochloride Tablets Product Portfolio Table 102. Takeda Recent Development Table 103. Teva Company Information Table 104. Teva Business Overview Table 105. Teva Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Teva Ondansetron Hydrochloride Tablets Product Portfolio Table 107. Teva Recent Development Table 108. PKU Healthcare Company Information Table 109. PKU Healthcare Business Overview Table 110. PKU Healthcare Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. PKU Healthcare Ondansetron Hydrochloride Tablets Product Portfolio Table 112. PKU Healthcare Recent Development Table 113. Ningbo Tianheng Pharmaceutical Company Information Table 114. Ningbo Tianheng Pharmaceutical Business Overview Table 115. Ningbo Tianheng Pharmaceutical Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Ningbo Tianheng Pharmaceutical Ondansetron Hydrochloride Tablets Product Portfolio Table 117. Ningbo Tianheng Pharmaceutical Recent Development Table 118. Qilu Pharmaceutical Company Information Table 119. Qilu Pharmaceutical Business Overview Table 120. Qilu Pharmaceutical Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Qilu Pharmaceutical Ondansetron Hydrochloride Tablets Product Portfolio Table 122. Qilu Pharmaceutical Recent Development Table 123. Shanghai Pharmaceuticals Company Information Table 124. Shanghai Pharmaceuticals Business Overview Table 125. Shanghai Pharmaceuticals Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Shanghai Pharmaceuticals Ondansetron Hydrochloride Tablets Product Portfolio Table 127. Shanghai Pharmaceuticals Recent Development Table 128. SJZ No.4 Pharmaceutical Company Information Table 129. SJZ No.4 Pharmaceutical Business Overview Table 130. SJZ No.4 Pharmaceutical Ondansetron Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. SJZ No.4 Pharmaceutical Ondansetron Hydrochloride Tablets Product Portfolio Table 132. SJZ No.4 Pharmaceutical Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Ondansetron Hydrochloride Tablets Distributors List Table 136. Ondansetron Hydrochloride Tablets Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Ondansetron Hydrochloride Tablets Product Image Figure 2. Global Ondansetron Hydrochloride Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ondansetron Hydrochloride Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Ondansetron Hydrochloride Tablets Sales (2021-2032) & (K Units) Figure 5. Global Ondansetron Hydrochloride Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ondansetron Hydrochloride Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Ordinary Tablets Image Figure 9. Oraliy Disintegrating Tablets Image Figure 10. Global Ondansetron Hydrochloride Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Ondansetron Hydrochloride Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Ondansetron Hydrochloride Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Ondansetron Hydrochloride Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Ondansetron Hydrochloride Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Ondansetron Hydrochloride Tablets Revenue Market Share by Type (2021-2032) Figure 16. Pharmacy Image Figure 17. Hospital and Clinic Image Figure 18. Other Image Figure 19. Global Ondansetron Hydrochloride Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Ondansetron Hydrochloride Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Ondansetron Hydrochloride Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Ondansetron Hydrochloride Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Ondansetron Hydrochloride Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Ondansetron Hydrochloride Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Ondansetron Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Ondansetron Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Ondansetron Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 39. China Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Ondansetron Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Ondansetron Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Ondansetron Hydrochloride Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Ondansetron Hydrochloride Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Ondansetron Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Ondansetron Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Ondansetron Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Ondansetron Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Ondansetron Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Ondansetron Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Ondansetron Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Ondansetron Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Ondansetron Hydrochloride Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Ondansetron Hydrochloride Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Ordinary Tablets
  • Oraliy Disintegrating Tablets
Applications
  • Pharmacy
  • Hospital and Clinic
  • Other
Companies covered
  • GSK
  • Aden Healthcare
  • Aurobindo Pharma
  • Henry Schein
  • Morningside Pharmaceuticals
  • Mylan
  • Novartis
  • Takeda
  • Teva
  • PKU Healthcare
  • Ningbo Tianheng Pharmaceutical
  • Qilu Pharmaceutical
  • Shanghai Pharmaceuticals
  • SJZ No.4 Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ondansetron Hydrochloride Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ondansetron Hydrochloride Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ondansetron Hydrochloride Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ondansetron Hydrochloride Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ondansetron Hydrochloride Tablets Market Dynamics
  1. 2.1 Ondansetron Hydrochloride Tablets Industry Trends
  2. 2.2 Ondansetron Hydrochloride Tablets Industry Drivers
  3. 2.3 Ondansetron Hydrochloride Tablets Industry Opportunities and Challenges
  4. 2.4 Ondansetron Hydrochloride Tablets Industry Restraints
3 Ondansetron Hydrochloride Tablets Market by Manufacturers
  1. 3.1 Global Ondansetron Hydrochloride Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ondansetron Hydrochloride Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ondansetron Hydrochloride Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ondansetron Hydrochloride Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ondansetron Hydrochloride Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ondansetron Hydrochloride Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Ondansetron Hydrochloride Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ondansetron Hydrochloride Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ondansetron Hydrochloride Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ondansetron Hydrochloride Tablets Tier 1, Tier 2, and Tier 3
4 Ondansetron Hydrochloride Tablets Market by Type
  1. 4.1 Ondansetron Hydrochloride Tablets Type Introduction
  2. 4.1.1 Ordinary Tablets
  3. 4.1.2 Oraliy Disintegrating Tablets
  4. 4.2 Global Ondansetron Hydrochloride Tablets Sales by Type
  5. 4.2.1 Global Ondansetron Hydrochloride Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ondansetron Hydrochloride Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Ondansetron Hydrochloride Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Ondansetron Hydrochloride Tablets Revenue by Type
  9. 4.3.1 Global Ondansetron Hydrochloride Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ondansetron Hydrochloride Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Ondansetron Hydrochloride Tablets Revenue Market Share by Type (2021-2032)
5 Ondansetron Hydrochloride Tablets Market by Application
  1. 5.1 Ondansetron Hydrochloride Tablets Application Introduction
  2. 5.1.1 Pharmacy
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Other
  5. 5.2 Global Ondansetron Hydrochloride Tablets Sales by Application
  6. 5.2.1 Global Ondansetron Hydrochloride Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ondansetron Hydrochloride Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Ondansetron Hydrochloride Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Ondansetron Hydrochloride Tablets Revenue by Application
  10. 5.3.1 Global Ondansetron Hydrochloride Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ondansetron Hydrochloride Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Ondansetron Hydrochloride Tablets Revenue Market Share by Application (2021-2032)
6 Global Ondansetron Hydrochloride Tablets Sales by Region
  1. 6.1 Global Ondansetron Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ondansetron Hydrochloride Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Ondansetron Hydrochloride Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Ondansetron Hydrochloride Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ondansetron Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ondansetron Hydrochloride Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ondansetron Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ondansetron Hydrochloride Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ondansetron Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ondansetron Hydrochloride Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ondansetron Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ondansetron Hydrochloride Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ondansetron Hydrochloride Tablets Revenue by Region
  1. 7.1 Global Ondansetron Hydrochloride Tablets Revenue by Region
  2. 7.1.1 Global Ondansetron Hydrochloride Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ondansetron Hydrochloride Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Ondansetron Hydrochloride Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Ondansetron Hydrochloride Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ondansetron Hydrochloride Tablets Revenue (2021-2032)
  8. 7.2.2 North America Ondansetron Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ondansetron Hydrochloride Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Ondansetron Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ondansetron Hydrochloride Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ondansetron Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ondansetron Hydrochloride Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ondansetron Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Ondansetron Hydrochloride Tablets Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Aden Healthcare
  8. 8.2.1 Aden Healthcare Company Information
  9. 8.2.2 Aden Healthcare Business Overview
  10. 8.2.3 Aden Healthcare Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aden Healthcare Ondansetron Hydrochloride Tablets Product Portfolio
  12. 8.2.5 Aden Healthcare Recent Developments
  13. 8.3 Aurobindo Pharma
  14. 8.3.1 Aurobindo Pharma Company Information
  15. 8.3.2 Aurobindo Pharma Business Overview
  16. 8.3.3 Aurobindo Pharma Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aurobindo Pharma Ondansetron Hydrochloride Tablets Product Portfolio
  18. 8.3.5 Aurobindo Pharma Recent Developments
  19. 8.4 Henry Schein
  20. 8.4.1 Henry Schein Company Information
  21. 8.4.2 Henry Schein Business Overview
  22. 8.4.3 Henry Schein Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Henry Schein Ondansetron Hydrochloride Tablets Product Portfolio
  24. 8.4.5 Henry Schein Recent Developments
  25. 8.5 Morningside Pharmaceuticals
  26. 8.5.1 Morningside Pharmaceuticals Company Information
  27. 8.5.2 Morningside Pharmaceuticals Business Overview
  28. 8.5.3 Morningside Pharmaceuticals Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Morningside Pharmaceuticals Ondansetron Hydrochloride Tablets Product Portfolio
  30. 8.5.5 Morningside Pharmaceuticals Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Ondansetron Hydrochloride Tablets Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Novartis
  38. 8.7.1 Novartis Company Information
  39. 8.7.2 Novartis Business Overview
  40. 8.7.3 Novartis Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Novartis Ondansetron Hydrochloride Tablets Product Portfolio
  42. 8.7.5 Novartis Recent Developments
  43. 8.8 Takeda
  44. 8.8.1 Takeda Company Information
  45. 8.8.2 Takeda Business Overview
  46. 8.8.3 Takeda Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Takeda Ondansetron Hydrochloride Tablets Product Portfolio
  48. 8.8.5 Takeda Recent Developments
  49. 8.9 Teva
  50. 8.9.1 Teva Company Information
  51. 8.9.2 Teva Business Overview
  52. 8.9.3 Teva Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Ondansetron Hydrochloride Tablets Product Portfolio
  54. 8.9.5 Teva Recent Developments
  55. 8.10 PKU Healthcare
  56. 8.10.1 PKU Healthcare Company Information
  57. 8.10.2 PKU Healthcare Business Overview
  58. 8.10.3 PKU Healthcare Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 PKU Healthcare Ondansetron Hydrochloride Tablets Product Portfolio
  60. 8.10.5 PKU Healthcare Recent Developments
  61. 8.11 Ningbo Tianheng Pharmaceutical
  62. 8.11.1 Ningbo Tianheng Pharmaceutical Company Information
  63. 8.11.2 Ningbo Tianheng Pharmaceutical Business Overview
  64. 8.11.3 Ningbo Tianheng Pharmaceutical Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ningbo Tianheng Pharmaceutical Ondansetron Hydrochloride Tablets Product Portfolio
  66. 8.11.5 Ningbo Tianheng Pharmaceutical Recent Developments
  67. 8.12 Qilu Pharmaceutical
  68. 8.12.1 Qilu Pharmaceutical Company Information
  69. 8.12.2 Qilu Pharmaceutical Business Overview
  70. 8.12.3 Qilu Pharmaceutical Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Qilu Pharmaceutical Ondansetron Hydrochloride Tablets Product Portfolio
  72. 8.12.5 Qilu Pharmaceutical Recent Developments
  73. 8.13 Shanghai Pharmaceuticals
  74. 8.13.1 Shanghai Pharmaceuticals Company Information
  75. 8.13.2 Shanghai Pharmaceuticals Business Overview
  76. 8.13.3 Shanghai Pharmaceuticals Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shanghai Pharmaceuticals Ondansetron Hydrochloride Tablets Product Portfolio
  78. 8.13.5 Shanghai Pharmaceuticals Recent Developments
  79. 8.14 SJZ No.4 Pharmaceutical
  80. 8.14.1 SJZ No.4 Pharmaceutical Company Information
  81. 8.14.2 SJZ No.4 Pharmaceutical Business Overview
  82. 8.14.3 SJZ No.4 Pharmaceutical Ondansetron Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 SJZ No.4 Pharmaceutical Ondansetron Hydrochloride Tablets Product Portfolio
  84. 8.14.5 SJZ No.4 Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ondansetron Hydrochloride Tablets Value Chain Analysis
  2. 9.1.1 Ondansetron Hydrochloride Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ondansetron Hydrochloride Tablets Production Mode & Process
  6. 9.2 Ondansetron Hydrochloride Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ondansetron Hydrochloride Tablets Distributors
  9. 9.2.3 Ondansetron Hydrochloride Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst